The AlncRNA delivered by an adenoviral vector inhibits the activation of AKT by blocking the functions of the miRNAs, and enhances the efficacy of sorafenib in suppressing HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.